Disclosures for "Tumefactive Demyelination in NMOSD Presenting as a Thalamic Lesion With Midline Shift"
-
Dr. Kiapour has nothing to disclose.
-
Dr. Herrera has nothing to disclose.
-
Author has nothing to disclose
-
Ms. Duran has nothing to disclose.
-
Dr. Esfahanizadeh has nothing to disclose.
-
Dr. Bhise has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharmaceuticals. The institution of Dr. Bhise has received research support from Horizon Blue Cross Blue Shield.